At this event, you will learn how the team at the MassGeneral Institute for Neurodegenerative Disease is working to identify new therapeutic targets for ALS.
https://iamals.org/action/physicians-perceptions-of-people-with-disability-and-their-health-care/ Having a disability shouldn’t lead to receiving substandard care, symptoms and primary health care concerns overlooked or pain or discomfort ignored. Unfortunately this happens all too often and isn’t […]
Join us for a HEALEY ALS Platform Trial Q&A Our investigators and study team will be available to answer any and all questions that the you might have about the […]
Join us for a HEALEY ALS Platform Trial Q&A Our investigators and study team will be available to answer any and all questions that the you might have about the […]
Join us via zoom for an in depth scientific on why the brain matters in ALS. Moderated by: Doug McConnell, A Long Swim Co-Founder Hosted by: Dr. Hande Ozdinler, Scientific […]
From Center for Medicare Advocacy - Practical points as well as advocacy topics.
Neuroinflammation is a major driving force in the pathophysiology of the neurodegenerative diseases ALS and Alzheimer Disease. Such neuroinflammation is characterized by alterations of the immune system - primarily the […]
Featuring Melinda Kavanaugh, PhD, MSW, LCSW, Associate Professor, Social Work and Director in Social Welfare at the Helen Bader School of Social Welfare at the University of […]
Join us for a HEALEY ALS Platform Trial Q&A Our investigators and study team will be available to answer any and all questions that the you might have about the […]
Announcing a new NEALS webinar series on ALS drug development moderated by Dr. Richard Bedlack from the Duke ALS Clinic. This series will include talks on the preclinical development of […]
Our March webinar focused on talking with children about ALS. In April, we shift the discussion to how children cope with grief and loss. This webinar integrates Dr. Kavanaugh’s clinical […]